Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Etiproston Tromethamine
1. 59619-81-7
2. Etiprostone
3. Etiproston [inn]
4. Prostavet
5. Tcu22w0apy
6. (z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(e)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]hept-5-enoic Acid
7. Etiproston (inn)
8. (z)-7-((1r,2r,3r,5s)-3,5-dihydroxy-2-((e)-2-(2-(phenoxymethyl)-1,3-dioxolan-2-yl)vinyl)cyclopentyl)-5-heptenoic Acid
9. Etiprostonum
10. Etiprostone [inn-french]
11. Unii-tcu22w0apy
12. Etiprostonum [inn-latin]
13. Brn 1274276
14. Etiproston [mi]
15. Prostavet [veterinary] (tn)
16. Chembl2104285
17. Schembl11602088
18. Dtxsid501024232
19. Zinc30691625
20. 15-deoxy-15,15-ethylenedioxy-16-phenoxy-17,18,19,20-tetranor-pgf2-alpha
21. 15-deoxy-15,15-ethylenedioxy-16-phenoxy-17,18,19,20-tetranor-prostaglandin F2-alpha
22. D07932
23. 619e817
24. Q27289904
25. 15-deoxy-15, 15-ethylenedioxy-16-phenoxy-omega-tetranor Pgf-2alpha
26. 5-heptenoic Acid, 7-(3,5-dihydroxy-2-(2-(2-(phenoxymethyl)-1,3-dioxolan-2-yl)ethenyl)cyclopentyl)-, (1r-(1-alpha(z),2-beta(e),3-alpha,5-alpha))-
| Molecular Weight | 432.5 g/mol |
|---|---|
| Molecular Formula | C24H32O7 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 11 |
| Exact Mass | 432.21480336 g/mol |
| Monoisotopic Mass | 432.21480336 g/mol |
| Topological Polar Surface Area | 105 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 605 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
93
PharmaCompass offers a list of Etiproston API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Etiproston manufacturer or Etiproston supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Etiproston manufacturer or Etiproston supplier.
A Prostavet [veterinary] (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prostavet [veterinary] (TN), including repackagers and relabelers. The FDA regulates Prostavet [veterinary] (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prostavet [veterinary] (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prostavet [veterinary] (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Prostavet [veterinary] (TN) supplier is an individual or a company that provides Prostavet [veterinary] (TN) active pharmaceutical ingredient (API) or Prostavet [veterinary] (TN) finished formulations upon request. The Prostavet [veterinary] (TN) suppliers may include Prostavet [veterinary] (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of Prostavet [veterinary] (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
Prostavet [veterinary] (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prostavet [veterinary] (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Prostavet [veterinary] (TN) GMP manufacturer or Prostavet [veterinary] (TN) GMP API supplier for your needs.
A Prostavet [veterinary] (TN) CoA (Certificate of Analysis) is a formal document that attests to Prostavet [veterinary] (TN)'s compliance with Prostavet [veterinary] (TN) specifications and serves as a tool for batch-level quality control.
Prostavet [veterinary] (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Prostavet [veterinary] (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prostavet [veterinary] (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Prostavet [veterinary] (TN) EP), Prostavet [veterinary] (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prostavet [veterinary] (TN) USP).
